announcements / 11.21.19
In a #WhyIScience Q&A, Diabetes genetics researcher Josep Mercader talks about the benefits and challenges of a career analyzing large and diverse datasets.
announcements / 11.18.19
Watch Anna Greka and Flo Wagner's talk on the past, present, and future of drug discovery.
announcements / 10.29.19
In a #WhyIScience Q&A, Julian Avila-Pacheco talks about his post-PhD career path and how he has tackled imposter syndrome as a minority scientist.
announcements / 10.01.19
In their own words, scientists from Dana-Farber and Broad's Cancer Program, Genetic Perturbation Platform, Proteomics Platform, and Metabolism Program describe how their collaboration revealed key changes in metabolism in drug-resistant leukemia cells.
announcements / 09.17.19
Katie Geiger-Schuller sifts through thousands of genes in search of new drug targets.
announcements / 08.20.19
Genomics is increasingly grappling with complex issues. Bioethics@Broad provides a space to talk about them.
announcements / 08.08.19
In a #WhyIScience Q&A, the machine learning scientist discusses his background in theoretical physics and what drew him to biomedical research.
announcements / 07.23.19
In a #WhyIScience Q&A, the Cancer Dependency Map project manager discusses how she has combined skills in communications, design, and biology to forge a unique career path.
announcements / 06.07.19
In a #WhyIScience Q&A, the longtime group leader from the Broad’s Cancer Program recounts his move from molecular to computational biology and talks about the collaborative effort that went into The Cancer Genome Atlas